Ibrahim Ramzi, Patel Dwani, Pham Hoang Nhat, Abdelnabi Mahmoud, Pathangey Girish, Motairek Issam, Nasir Khurram, Al-Kindi Sadeer
Department of Cardiovascular Medicine, Mayo Clinic, Phoenix, Arizona, USA.
Department of Medicine, University of Arizona Tucson, Tucson, Arizona, USA.
JACC Adv. 2025 Jun;4(6 Pt 2):101830. doi: 10.1016/j.jacadv.2025.101830.
Cardio-kidney-metabolic (CKM) diseases impact a large portion of the U.S. population each year, particularly among racial minorities and socially disadvantaged groups. Social factors contribute to this disparity, including barriers to healthcare access, structural racism, and sociocultural influences.
This scoping review aimed to assess the understanding of how historical redlining has affected the prevalence and outcomes of CKM diseases.
We conducted a scoping review of multiple databases to identify studies examining the relationship between historical redlining and the risk factors, prevalence, and outcomes associated with CKM diseases. Data extraction focused on the type of study, linked databases, research questions, primary outcomes, and study quality.
From an initial pool of 176 studies identified, 13 were included. Among these, 6 studies explored the impact of historical redlining on cardiovascular disease risk factors, prevalence, and metabolic disorders; 2 studies examined historical redlining in relation to heart failure; 2 studies focused on kidney disease; and 3 studies investigated atherosclerotic disease. Our findings indicate an association between historically redlined regions and increased prevalence of cardiovascular disease risk factors, heart failure events, metabolic disease burden, and kidney failure incidence. The appraisal of these studies showed that the majority met 20 to 22 of the criteria outlined in the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist.
This scoping review highlighted significant associations between historically redlined neighborhoods in the United States and the prevalence and outcomes of CKM diseases. These findings have revealed the potential impact of structural racism and discriminatory practices on healthcare inequities.
心脏-肾脏-代谢(CKM)疾病每年影响着很大一部分美国人口,尤其是在少数族裔和社会弱势群体中。社会因素导致了这种差异,包括医疗保健获取障碍、结构性种族主义和社会文化影响。
本范围综述旨在评估对历史上的红线划定如何影响CKM疾病的患病率和结局的理解。
我们对多个数据库进行了范围综述,以识别研究历史红线划定与CKM疾病相关的危险因素、患病率和结局之间关系的研究。数据提取集中在研究类型、链接的数据库、研究问题、主要结局和研究质量上。
从最初识别出的176项研究中,纳入了13项。其中,6项研究探讨了历史红线划定对心血管疾病危险因素、患病率和代谢紊乱的影响;2项研究考察了历史红线划定与心力衰竭的关系;2项研究关注肾脏疾病;3项研究调查了动脉粥样硬化疾病。我们的研究结果表明,历史上被划定为红线的地区与心血管疾病危险因素患病率增加、心力衰竭事件、代谢疾病负担和肾衰竭发病率之间存在关联。对这些研究的评估表明,大多数研究符合《流行病学观察性研究报告强化规范》(STROBE)清单中列出的20至22条标准。
本范围综述突出了美国历史上被划定为红线的社区与CKM疾病的患病率和结局之间的显著关联。这些发现揭示了结构性种族主义和歧视性做法对医疗保健不公平的潜在影响。